Aqabela
Microbiome-based drinking water formulation for pharma partners developing treatments for chronic inflammatory and respiratory disease
Highlights
- New on EvolcAdded 2026-11-13
About Aqabela
Aqabela develops BRIDGE, a patent-protected oral drinking water formulation designed to restore gut microbiome function and stimulate the production of bioactive molecules such as butyrate and hydrogen sulfide. Reported results include in vitro data, preclinical data in a lethal respiratory viral infection model, and an initial human pilot showing improvements in glucose control and systemic oxygenation.
The company is seeking pharmaceutical partners to advance BRIDGE toward clinical testing and says it is currently completing the IND-enabling development package. Target areas include respiratory viral infection and chronic inflammatory diseases, including comorbidities such as diabetes. A separate section lists food applications for health-impacting packaged food.
Aqabela was founded in 2020 and is headquartered in Belfast, United Kingdom, through AQABELA LTD. It operates alongside AQABELA.EU SIA in Latvia. The founders are Scott Parkinson PhD, a former R&D leader at Novartis and Nestlé; Monta Niedola MD; and Kristaps Niedols BEng, who leads execution across the business.
Product: BRIDGE, a patent-protected drinking water formulation intended to restore gut microbiome function in chronic inflammatory and respiratory disease, at preclinical and early human pilot stage.
Jobs at Aqabela
Leadership
- Kristaps Niedols · BEngSource: company website
- Monta Niedola · MDSource: company website
- Scott Parkinson · PhDSource: company website
More biotech & pharma companies
Arctorians
Automated drug discovery research and experimental data services for biotech, techbio and pharmaceutical companiesArecor
Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseasesArkvax
Develops glycoconjugate vaccines for animal health and antimicrobial resistance preventionNew on EvolcAspire Biosciences
Rare-disease partnering events and a searchable platform matching patient organisations with drug development companiesYoung companyNew on EvolcAspire Laboratories
Contract analytical and microbiological testing for pharmaceutical, cosmetics, veterinary, healthcare and medical-device companiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.